Diabetes drug Avandia, has been associated with various diseases like heart attacks, heart failure, bone fractures, anemia and retinal edema with vision loss. As a result, the non-profit body called Public Citizen has filed a petition to the FDA to ban the drug. Avandia Plaintiffs Steering Committee has confirmed it.
The application is based on the documentation of the clinical studies on all these diseases mentioned above. Perhaps most seriously, the group analyzed 14 cases of liver failure in patients who were taking Avandia, 12 of which resulted in death.
The Avandia Plaintiffs Steering Committee has been tracking the reports of multiple serious side effects from Avandia for the past year and represents a number of plaintiffs in litigation against the manufacturer of the drug, GlaxoSmithKline. Many nationwide lawsuits have been centralized in Federal court in the Eastern District of Pennsylvania in front of Hon. Cynthia Rufe, (In Re: Avandia Marketing, Sales Practices and Products Liability Litigation, 2:07-md-01871-CMR). This litigation involves thousands of claims for injuries ranging from death and heart attack to vision loss and bone fractures.
Vance Andrus, lead counsel for the Avandia Plaintiffs Steering Committee said,
“The Public Citizen petition, along with prior recommendations against the use of Avandia from both the American Diabetes Association and the European Association for the Study of Diabetes, is certainly a step in the right direction. Many doctors and patients were led to believe that this was a safe and effective drug and, as a result, their lives were put in danger.”